Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of LanifibranorGlobeNewsWire • 04/22/26
Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-FGlobeNewsWire • 04/08/26
Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial ResultsGlobeNewsWire • 03/23/26
Inventiva S.A. (IVA) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking Alpha • 03/11/26
Does Inventiva (IVA) Have the Potential to Rally 136.34% as Wall Street Analysts Expect?Zacks Investment Research • 02/27/26
Wall Street Analysts Predict a 200.59% Upside in Inventiva (IVA): Here's What You Should KnowZacks Investment Research • 01/08/26
Inventiva announces full exercise of Underwriters' Option, bringing proceeds of Offering to approximately $172.5MGlobeNewsWire • 11/17/25
Inventiva announces trading resumption of its ordinary shares on Euronext ParisGlobeNewsWire • 11/13/25
Inventiva announces pricing of upsized public offering of approximately $150M of American Depositary SharesGlobeNewsWire • 11/13/25
Inventiva announces temporary trading halt of its ordinary shares on Euronext ParisGlobeNewsWire • 11/13/25